Prevalence of the c.853delT Mutation of the HOXB13 Gene in Prostate Cancer in Martinique
NCT05231915
Summary
In Martinique, prostate cancer incidence rates are nowadays among the highest worldwide with a high incidence of early-onset and familial forms. We identified a rare heterozygous germline variant c.853delT (p.Ter285Lysfs) rs77179853, reported only among patients of African ancestry with a minor allele frequency of 3.2%. We search to estimate the prevalence of this variant in a sample of prevalent prostate cancer cases managed in urology consultation in Martinique .
Eligibility
Inclusion Criteria: * Adult man over 18 years of age living in Martinique with a prostate cancer whatever the histological type and the stage, managed in urology consultation (public and private sectors of Martinique) * Sporadic or familial form * Informed with a written consent signed by the participant and the investigator * Affiliate or beneficiary of french social security. Exclusion Criteria: * Patient who is not of African descent * Refusal to participate. * Patients not affiliated to french social security
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05231915